IL6 and pulmonary fibrosis: Recent publications have reported, though, that it is the activation of the A2B receptor by adenosine that mediates production of pro-inflammatory, pro-fibrotic molecules, like interleukin-6, leading to chronic lung diseases, particularly pulmonary fibrosis (11, 118, 132, 134, 135).